Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Isla

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Thrombosis Research|February 5, 2014
Adjuvant therapy with bemiparin in patients with limited-stage small cell lung cancer: results from the ABEL studyR Lecumberri, G López Vivanco, A Font, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 1, 2017
Erratum to: Equity, barriers and cancer disparities: study of the Spanish Society of Medical Oncology on the access to oncologic drugs in the Spanish RegionsJ Salvador, J Aparicio, F J Baron, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 30, 2017
Efficacy of tyrosine kinase inhibitors in EGFR-mutant lung cancer women in a real-world setting: the WORLD07 databaseJ Remon, D Isla, P Garrido, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2004
Single nucleotide polymorphisms and outcome in docetaxel-cisplatin-treated advanced non-small-cell lung cancerD Isla, C Sarries, R Rosell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2006
Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patientsR de las Peñas, M Sanchez-Ronco, V Alberola, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 2005
Randomized phase III study of 3-weekly versus weekly docetaxel in pretreated advanced non-small-cell lung cancer: a Spanish Lung Cancer Group trialC Camps, B Massuti, A Jiménez, et al.
ESMO Open|February 8, 2021
Gender influence on work satisfaction and leadership for medical oncologists: a survey of the Spanish Society of Medical Oncology (SEOM)E Elez, F Ayala, E Felip, et al.
The European Respiratory Journal|July 3, 2010
Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutationR Porta, J M Sánchez-Torres, L Paz-Ares, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 30, 2010
Treatment of cancer with oral drugs: a position statement by the Spanish Society of Medical Oncology (SEOM)R Colomer, E Alba, A González-Martin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 30, 2003
Cisplatin plus gemcitabine versus a cisplatin-based triplet versus nonplatinum sequential doublets in advanced non-small-cell lung cancer: a Spanish Lung Cancer Group phase III randomized trialV Alberola, C Camps, M Provencio, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Thrombosis Research|February 5, 2014
Adjuvant therapy with bemiparin in patients with limited-stage small cell lung cancer: results from the ABEL studyR Lecumberri, G López Vivanco, A Font, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 1, 2017
Erratum to: Equity, barriers and cancer disparities: study of the Spanish Society of Medical Oncology on the access to oncologic drugs in the Spanish RegionsJ Salvador, J Aparicio, F J Baron, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 30, 2017
Efficacy of tyrosine kinase inhibitors in EGFR-mutant lung cancer women in a real-world setting: the WORLD07 databaseJ Remon, D Isla, P Garrido, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2004
Single nucleotide polymorphisms and outcome in docetaxel-cisplatin-treated advanced non-small-cell lung cancerD Isla, C Sarries, R Rosell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2006
Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patientsR de las Peñas, M Sanchez-Ronco, V Alberola, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 2005
Randomized phase III study of 3-weekly versus weekly docetaxel in pretreated advanced non-small-cell lung cancer: a Spanish Lung Cancer Group trialC Camps, B Massuti, A Jiménez, et al.
ESMO Open|February 8, 2021
Gender influence on work satisfaction and leadership for medical oncologists: a survey of the Spanish Society of Medical Oncology (SEOM)E Elez, F Ayala, E Felip, et al.
The European Respiratory Journal|July 3, 2010
Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutationR Porta, J M Sánchez-Torres, L Paz-Ares, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 30, 2010
Treatment of cancer with oral drugs: a position statement by the Spanish Society of Medical Oncology (SEOM)R Colomer, E Alba, A González-Martin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 30, 2003
Cisplatin plus gemcitabine versus a cisplatin-based triplet versus nonplatinum sequential doublets in advanced non-small-cell lung cancer: a Spanish Lung Cancer Group phase III randomized trialV Alberola, C Camps, M Provencio, et al.
Pageof 5